Hengyi Wang

526 total citations
23 papers, 371 citations indexed

About

Hengyi Wang is a scholar working on Pathology and Forensic Medicine, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hengyi Wang has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hengyi Wang's work include Nerve injury and regeneration (4 papers), Spinal Cord Injury Research (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). Hengyi Wang is often cited by papers focused on Nerve injury and regeneration (4 papers), Spinal Cord Injury Research (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). Hengyi Wang collaborates with scholars based in China. Hengyi Wang's co-authors include Yuanliang Xia, Changfeng Fu, Yuehong Li, Ruohan Yang, Jie Li, Jiawei Fan, Xingyu Wang, Weihao Kong, Lu Liu and Shiyun Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Hydrogen Energy and Frontiers in Immunology.

In The Last Decade

Hengyi Wang

23 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengyi Wang China 13 104 82 73 61 56 23 371
Yuanliang Xia China 11 98 0.9× 78 1.0× 75 1.0× 56 0.9× 32 0.6× 15 305
Nicolas Védrenne France 11 198 1.9× 49 0.6× 52 0.7× 53 0.9× 84 1.5× 18 544
M. N Zhuravleva Russia 10 109 1.0× 29 0.4× 47 0.6× 33 0.5× 36 0.6× 31 325
Yanming Qu China 13 156 1.5× 36 0.4× 67 0.9× 18 0.3× 51 0.9× 41 431
Ankai Xu China 11 219 2.1× 107 1.3× 78 1.1× 172 2.8× 101 1.8× 14 545
Cheong-Soo Park South Korea 9 157 1.5× 32 0.4× 97 1.3× 87 1.4× 46 0.8× 23 452
Zarema Gilazieva Russia 11 205 2.0× 24 0.3× 99 1.4× 47 0.8× 94 1.7× 17 391
Nassir M. Mansour United States 9 128 1.2× 59 0.7× 53 0.7× 19 0.3× 21 0.4× 15 361
Arshia Ehsanipour United States 10 115 1.1× 94 1.1× 190 2.6× 19 0.3× 89 1.6× 11 469

Countries citing papers authored by Hengyi Wang

Since Specialization
Citations

This map shows the geographic impact of Hengyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengyi Wang more than expected).

Fields of papers citing papers by Hengyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengyi Wang. The network helps show where Hengyi Wang may publish in the future.

Co-authorship network of co-authors of Hengyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hengyi Wang. A scholar is included among the top collaborators of Hengyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengyi Wang. Hengyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lian-Xin, Jie Wang, Yuying Zhang, et al.. (2024). Construction of highly active and stable recombinant nattokinase by engineered bacteria and computational design. Archives of Biochemistry and Biophysics. 760. 110126–110126. 2 indexed citations
2.
Li, Shenghao, et al.. (2024). The current status and future of targeted-immune combination for hepatocellular carcinoma. Frontiers in Immunology. 15. 1418965–1418965. 16 indexed citations
3.
Yang, Guangmin, Xiaojie Liu, Hengyi Wang, et al.. (2024). Construction of 3D LaCoO3/CdS S-scheme heterojunction for enhanced charge transfer capability and photocatalytic hydrogen production activity. International Journal of Hydrogen Energy. 91. 393–403. 8 indexed citations
4.
Wang, Hengyi, Yongfei Li, Mingyu Dou, et al.. (2024). Visible-light driven S-scheme Bi2WO6/graphitic carbon nitride heterojunction for efficient simultaneous removal of TC and Cr(VI). Journal of Alloys and Compounds. 1010. 177669–177669. 4 indexed citations
5.
Wu, Qiusheng, et al.. (2024). The hidden diversity and functional potential of Chloroflexota genomes in arsenic and antimony co-contaminated soils. Soil Ecology Letters. 7(1). 3 indexed citations
6.
Fan, Jiawei, et al.. (2023). Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy. Frontiers in Pharmacology. 14. 1271321–1271321. 6 indexed citations
7.
Wang, Hengyi, Qiao Zheng, Jingwen Liu, et al.. (2023). Add fuel to the fire: Inflammation and immune response in lung cancer combined with COVID-19. Frontiers in Immunology. 14. 1174184–1174184. 4 indexed citations
8.
Fan, Jiawei, et al.. (2023). Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases. Frontiers in Immunology. 14. 1219487–1219487. 18 indexed citations
9.
Xia, Yuanliang, et al.. (2023). Biomaterials delivery strategies to repair degenerated intervertebral discs by regulating the inflammatory microenvironment. Frontiers in Immunology. 14. 1051606–1051606. 17 indexed citations
10.
Xia, Yuanliang, et al.. (2023). Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges. Frontiers in Immunology. 14. 1141601–1141601. 51 indexed citations
11.
Wang, Hengyi, et al.. (2023). Purine and purinergic receptors in health and disease. SHILAP Revista de lepidopterología. 4(5). e359–e359. 24 indexed citations
12.
Wang, Hengyi, et al.. (2023). Application of platelet-rich plasma in spinal surgery. Frontiers in Endocrinology. 14. 1138255–1138255. 13 indexed citations
13.
Xia, Yuanliang, et al.. (2022). Application of mesenchymal stem cell-derived exosomes from different sources in intervertebral disc degeneration. Frontiers in Bioengineering and Biotechnology. 10. 1019437–1019437. 39 indexed citations
14.
Wang, Hengyi, et al.. (2022). Reverse Adverse Immune Microenvironments by Biomaterials Enhance the Repair of Spinal Cord Injury. Frontiers in Bioengineering and Biotechnology. 10. 812340–812340. 13 indexed citations
15.
Xia, Yuanliang, Ruohan Yang, Hengyi Wang, et al.. (2022). Engineered nanomaterials trigger abscopal effect in immunotherapy of metastatic cancers. Frontiers in Bioengineering and Biotechnology. 10. 890257–890257. 13 indexed citations
16.
Li, Jie, et al.. (2021). Physical Cues of Matrices Reeducate Nerve Cells. Frontiers in Cell and Developmental Biology. 9. 731170–731170. 7 indexed citations
17.
Li, Jie, et al.. (2020). Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy. Frontiers in Bioengineering and Biotechnology. 8. 612950–612950. 45 indexed citations
18.
Kong, Weihao, Jun Zheng, Liang Chen, et al.. (2020). Mean Corpuscular Hemoglobin Concentration Correlates with Prognosis of Resected Hepatocellular Carcinoma. Biomarkers in Medicine. 14(4). 259–270. 11 indexed citations
19.
Tang, Qinqing, et al.. (2019). Effect of PI3K/PKB signal pathway inhibitor wortmannin pretreatmenton intestinal barrier function in severe acute pancreatitic rats. Advances in Clinical and Experimental Medicine. 28(8). 1059–1066. 4 indexed citations
20.
Kong, Weihao, Mingwei Yang, Qihang Chen, et al.. (2019). Prognostic value of microRNA-451 in various cancers: A meta-analysis. Pathology - Research and Practice. 215(12). 152726–152726. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026